The Senior Payer Policy and Relations Analyst is responsible for assisting the Director of Payer Policy and Relations with policy and alliance development activities for the company, including assistance with development and implementation of policy strategies to support LabCorp and the laboratory industry at the state and federal levels. The Analyst will act as internal conduit to gather and share information as it relates to policy, billing and reimbursement issues.
Duties and Responsibilities:
Works directly with Segment Marketing Management teams to develop an understanding of existing and emerging technologies to provide education, appeals influence and insight pertaining to payer policy for Government and Commercial payers.
Provide support to include attending Payer meetings with Managed Care Account Executives to communicate specific policy concerns and denials trends.
Regularly monitors payer policy updates and changes such as NCD, LCD and other coverage policies impacting revenue.
Functions as a liaison between LabCorp Medical Directors and Government and Commercial Payer Medical Directors on issues pertaining to existing payer policies and proposed policy changes impacting reimbursement.
Will assist the Director with subject matter expertise for the development of comments on regulatory proposals, written testimony, policy position papers and regulations that affect the company, analyzing public policy, legislative and regulatory proposals, and reporting internally as required.
Coordinates with the Director and Vice President of Policy to help develop LabCorp's policy positions, strategy and tactics, and advocates company positions with regard to new or amended legislation, regulations, or public policy. Help support efforts in defending against risk of Medicare and private sector payer price erosion associated with the Protecting Access to Medicare Act of 2014(PAMA).
Supports efforts at the state and federal levels as appropriate by developing responses, talking points, strategy on key issues while helping to assure policy consistency across the organization.
Assists in advocating company positions orally and in writing before, during and after meetings at ACLA (the clinical laboratory trade association), with other trade and professional associations, with laboratory coalitions (e.g., BCBSA ICD-10 coalition or Clinical Lab Coalition), and others.
Communicates developments and updates on a regular basis through periodic reporting mechanisms and appropriate internal and external communications channels.
Examines health care trends, monitors implementation of the American Health Care Act to inform business of implications and identify potential opportunities and/or risk for Medicare, Medicaid, Accountable Care Organizations, and Commercial payers.
Maintains a thorough knowledge of the regulatory processes and policy developments on matters affecting the company.
Develops and maintains key contacts and relationships with policy makers for Medicare Contractors, Medicaid Payers and Commercial insurers. Ability to collaborate with third party groups affected by Medicare, Medicaid, and CLIA regulations that impact lab services.
Performs other and further duties and responsibilities as shall be assigned by the Director and/or Vice President of Payer Policy.
Requirements
Minimum of eight years prior experience working with state and federal agencies and understanding insurance guidelines. Required a Bachelor's degree from accredited four-year institution or equivalent experience; Preferred, an MBA, JD, M.A. / M.S. or other advanced degree in health policy.
Shift
1
Schedule
Monday-Friday; 8:00am-5:00pm
Burlington, NC
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
The company also provides testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides technology-enabled solutions, including a suite of applications to enable patients, healthcare providers, health systems, accountable care organizations, and insurers with convenient and secure access to LCD’s data and services, as well as billing for laboratory services. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from research to clinical development and commercial market access.
The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has collaborations with the Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, Yale University, and QIAGEN N.V. The company was founded in 1971 and is headquartered in Burlington, North Carolinia.